Acenewrax 200mg Mucolytic (5gm)

(Arabic translation – باللغة العربية)

Active ingredient: Acetylcystiene 200mg/5gm

–  Mucolytic
– According to management protocol for COVID-19.
– Acenewrax used in mild case (COVID-19).
– Acenewrax used in home isolation (Symptomatic treatment)
– Acenewrax used 3 times /day in isolation period.

Mechanism of action:

-Acetylcysteine exerts its mucolytic action through its free sulfhydryl group, which reduces the disulfide bonds in the mucus matrix and lowers mucus viscosity.

– Indications:

• Mucolytic adjuvant in the therapy of respiratory disorders associated with thick, viscous, mucus hypersecretion.
• Chronic bronchopulmonary disease , chronic emphysema , emphysema with bronchitis, chronic asthmatic bronchitis, tuberculosis, bronchiectasis and primary
• amyloidosis of the lung.
• Acute bronchopulmonary disease (pneumonia, bronchitis, tracheobronchitis).
• Pulmonary complications of cystic fibrosis.
• Tracheostomy care.
• Pulmonary complications associated with surgery.
• Use during anesthesia.
• Post-traumatic chest conditions.

Learn more about the Acenewrax Trial….. Click here